Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | CAD | P27708 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1332187 | 0.98 | LMNA (0.53) | LMNAALDH1A1HSD17B10GAAMGAM | |
| SCHEMBL1331748 | 0.98 | LMNA (0.53) | LMNAALDH1A1HSD17B10GAAMGAM | |
| SCHEMBL1330728 | 0.98 | LMNA (0.53) | LMNAALDH1A1HSD17B10GAAMGAM | |
| SCHEMBL81193 | 0.98 | LMNA (0.53) | LMNAALDH1A1HSD17B10GAAMGAM | |
| SCHEMBL1332017 | 0.98 | LMNA (0.53) | LMNAALDH1A1HSD17B10GAAMGAM | |
| Hydrochloric Acid SCHEMBL27898018 | 0.95 | LMNA (0.51) | LMNAALDH1A1HSD17B10GAAMGAM | |
| Alcohol SCHEMBL27600744 | 0.93 | LMNA (0.50) | LMNAALDH1A1HSD17B10GAAMGAM | |
| Acetic Acid SCHEMBL27299232 | 0.93 | LMNA (0.50) | LMNAALDH1A1HSD17B10GAAMGAM | |
| SCHEMBL16727820 | 0.91 | LMNA (0.49) | LMNAALDH1A1HSD17B10GAAMGAM | |
| Acetic Acid SCHEMBL27475348 | 0.91 | LMNA (0.49) | LMNAALDH1A1HSD17B10GAAMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3112340-B1 | METHOD FOR PRODUCING 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO, AND PRECURSOR OF 4-BORONO-L-PHENYLALANINE HAVING 18F ATOM INTRODUCED THEREINTO | STELLA PHARMA CORP (JP) | 2020-07-15 | — | — | EP | disclosed |
| CN-102887913-B | Method for synthesizing 4-dihydroxyborane-2-fluorophenylalanine | NANJING PET TRACER CO LTD | 2015-02-25 | — | — | CN | disclosed |
| CN-102887913-A | Method for synthesizing 4-dihydroxyborane-2-fluorophenylalanine | NANJING PET TRACER CO LTD | 2013-01-23 | — | — | CN | disclosed |
| US-7662572-B2 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC. (US) | 2010-02-16 | — | — | US | disclosed |
| US-20070099249-A1 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-05-03 | — | — | US | disclosed |
| WO-2007025129-A2 | COMPOSITIONS AND LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC. (US) | 2007-03-01 | — | — | WO | disclosed |
| CN-1198839-C | Novel dipeptide amidines as thrombin inhibitors | AIBET GMBH & CO KG (DE) | 2005-04-27 | — | — | CN | disclosed |
| CN-1175953-A | Novel dipeptide amidines as thrombin inhibitors | BASF AG (DE) | 1998-03-11 | — | — | CN | disclosed |
| US-5565480-A | ANGIOTENSIN II RECEPTOR ANTAGONIST; USEFUL IN REGULATING HYPERTENSION, TREATMENT OF CONGESTIVE HEART FAILURE, RENAL FAILURE AND GLUCOMA | SMITHKLINE BEECHAM CORPORATION (US) | 1996-10-15 | — | — | US | disclosed |
| US-5444081-A | Treatment of hypertension, congestive heart failure, renal failure, glaucoma | SMITHKLINE BEECHAM CORP (US) | 1995-08-22 | — | — | US | disclosed |
| US-5395827-A | Analgesic, anticonvulsant, antiepileptic and anxiolytic agents | GUILFORD PHARMACEUTICALS INC. (US) | 1995-03-07 | — | — | US | disclosed |
| WO-1993005772-A1 | φ-[2-(PHOSPHONOALKYL)PHENYL]-2-AMINOALKANOIC ACIDS AS ANTAGONISTS OF EXCITATORY AMINO ACID RECEPTORS | NOVA PHARMACEUTICAL CORPORATION (US) | 1993-04-01 | — | — | WO | disclosed |
| US-4483853-A | ANTICONVULSANTS | COLLINS JAMES F | 1984-11-20 | — | — | US | disclosed |
| US-4477391-A | Amino acid isomers, their production and their medicinal use | COLLINS JAMES F (GB) | 1984-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099249-A1 | Compositions and liquid crystals | FABP5, FABP1, SSB | LMNA 283/4885ALDH1A1 4540/4885HSD17B10 1353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.